tiprankstipranks
Catalyst Pharma (CPRX)
NASDAQ:CPRX
US Market
CPRX
Catalyst Pharma
RESEARCH TOOLSreports
Want to see CPRX full AI Analyst Report?

Catalyst Pharma (CPRX) Income Statement

2,542 Followers

Catalyst Pharma Income Statement

Last quarter (Q4 2025), Catalyst Pharma's total revenue was $152.61M, an increase of 7.61% from the same quarter last year. In Q4, Catalyst Pharma's net income was $52.70M. See Catalyst Pharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 588.99M$ 491.73M$ 398.20M$ 214.20M$ 140.83M
Gross Profit
$ 501.74M$ 422.89M$ 346.24M$ 179.81M$ 118.95M
Operating Expenses
$ 243.96M$ 227.76M$ 259.43M$ 77.97M$ 66.56M
Depreciation and Amortization
$ 37.50M$ 37.77M$ 32.88M$ 1.24M$ 192.00K
EBITDA
$ 321.01M$ 232.90M$ 119.69M$ 103.08M$ 52.58M
Operating Income
$ 257.78M$ 195.12M$ 86.81M$ 101.84M$ 52.38M
Other Income/Expenses
$ 25.74M$ 21.14M$ 7.70M$ 2.88M$ 282.00K
Pretax Income
$ 283.51M$ 216.26M$ 94.51M$ 104.72M$ 52.67M
Net Income
$ 214.33M$ 163.89M$ 71.41M$ 83.08M$ 39.48M
Per Share Metrics
Basic EPS
$ 1.75$ 1.38$ 0.67$ 0.80$ 0.38
Diluted EPS
$ 1.68$ 1.31$ 0.63$ 0.75$ 0.37
Weighted Average Shares Outstanding
 122.29M 118.46M 106.28M 103.37M 103.38M
Weighted Average Shares Outstanding (Diluted)
 127.26M 124.94M 113.75M 111.38M 107.80M
Currency in USD

Catalyst Pharma Earnings and Revenue History